Aquestive Therapeutics Analyst Ratings
Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target
Aquestive Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: LENZ Therapeutics (LENZ), MannKind (MNKD) and Aquestive Therapeutics (AQST)
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Palatin Technologies (PTN)
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Aquestive Therapeutics (AQST) and Inspire Medical Systems (INSP)
Aquestive Therapeutics Analyst Ratings
Aquestive Therapeutics Earns Buy Rating on Libervant's Pediatric Approval and Anaphylm's Market Potential
Lake Street Sticks to Its Buy Rating for Aquestive Therapeutics (AQST)
Buy Rating Affirmed for Aquestive Therapeutics Following FDA Approval and Growth Prospects
Aquestive Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: EFFECTOR Therapeutics (EFTR), Adagene (ADAG) and Aquestive Therapeutics (AQST)
Aquestive Therapeutics Analyst Ratings
Aquestive Therapeutics Analyst Ratings
Aquestive Therapeutics Analyst Ratings
Buy Rating Affirmed for Aquestive Therapeutics on Strong Phase 3 Results for Anaphylm With Raised Price Target
Analysts Are Bullish on Top Healthcare Stocks: InfuSystem Holdings, Inc. (INFU), Aquestive Therapeutics (AQST)
Aquestive Therapeutics Analyst Ratings
Analysts Conflicted on These Healthcare Names: Allogene Therapeutics (ALLO), Aquestive Therapeutics (AQST) and Allakos (ALLK)
Aquestive Therapeutics Analyst Ratings
No Data